Three trends impacting market access in the EU

The Parexel Podcast
04/01/2024 13 min Episodio 33
Three trends impacting market access in the EU

Listen "Three trends impacting market access in the EU"

Descargar episodio Ver en sitio original

Episode Synopsis

Rare disease drug developers face three major market access challenges in the EU market today. Parexel Pricing and Market Access expert, Sangeeta Budhia, shares what they need to know to succeed.

More episodes of the podcast The Parexel Podcast

Enabling Successful Sites, Episode 5: Strategies for improving communication between sites, sponsors and CROs 24/02/2025
Is there room for new COAs in neuroscience? 24/02/2025
Enabling Successful Sites: Episode 4, Part Two: Leveraging AI to improve patient recruitment and retention 06/01/2025
Enabling Successful Sites: Episode 4, Part One: Partnering with sites to improve patient recruitment and retention 06/01/2025
Leveraging people, processes and technology to deliver for biotech 06/12/2024
Navigating market access in neuroscience: Challenges and strategies 16/10/2024
Leveraging people, processes and technology to deliver for biotech 01/10/2024
De-risking Drug Development | Episode 5: Expand the use and value of your product over time 25/09/2024
De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval 25/09/2024
Podcast: Accelerated approvals – what’s next, confirmatory trials, access, and pricing 05/08/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA